Apellis Pharmaceuticals, Inc.APLSNASDAQ
Loading
SG&A Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+25.6%
5Y CAGR+31.6%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+25.6%/yr
vs +87.1%/yr prior
5Y CAGR
+31.6%/yr
Recent deceleration
Acceleration
-61.4pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.9x
Strong expansion
Streak
9 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $549.82M | +9.7% |
| 2024 | $501.05M | +0.0% |
| 2023 | $500.81M | +80.7% |
| 2022 | $277.16M | +56.8% |
| 2021 | $176.77M | +26.8% |
| 2020 | $139.40M | +109.8% |
| 2019 | $66.45M | +193.5% |
| 2018 | $22.64M | +116.4% |
| 2017 | $10.46M | +143.1% |
| 2016 | $4.30M | - |